RJFSA
MRTX

Raymond James Financial Services Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,409
Closed -$255K – 2838
2018
Q3 		$255K Sell
5,409
-810
-13% -$38.2K ﹤0.01% 2376
2018
Q2 		$307K Sell
6,219
-1,343
-18% -$66.3K ﹤0.01% 2211
2018
Q1 		$232K Sell
7,562
-3,764
-33% -$115K ﹤0.01% 2167
2017
Q4 		$207K Buy
+11,326
New +$207K ﹤0.01% 2242